US SB660 | 2019-2020 | 116th Congress
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on March 5 2019 - 25% progression, died in committee
Action: 2019-03-05 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 5 2019 - 25% progression, died in committee
Action: 2019-03-05 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to address abuse of the Food and Drug Administration's citizen petition process by brand drug manufacturers.
Title
Efficiency and Transparency in Petitions Act
Sponsors
| Sen. Mike Braun [R-IN] |
History
| Date | Chamber | Action |
|---|---|---|
| 2019-03-05 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Subjects
Administrative remedies
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Government information and archives
Health
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Government information and archives
Health
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/116th-congress/senate-bill/660/all-info |
| Text | https://www.congress.gov/116/bills/s660/BILLS-116s660is.pdf |
